Alamar Biosciences, Inc. — Investor Relations & Filings
Alamar Biosciences, Inc. is a commercial-stage proteomics company focused on powering precision proteomics for the earliest detection of disease. It develops and commercializes an automated, high-throughput, ultra-high sensitivity platform, including ARGO™ and NULISA™ technologies. This platform redefines protein biomarker detection by enabling the discovery of novel plasma biomarkers, even from low-volume specimens, that are often invisible with conventional immunoassays. The technology supports groundbreaking insights in biomarker discovery, drug development, and disease research, expanding applications across various conditions like Alzheimer's, TBI, and stroke, from pediatric to geriatric care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-08 | English | |
| 8-K | 2026-05-08 | English | |
| Major Shareholding Notification 2026 | 2026-04-23 | English | |
| Major Shareholding Notification 2026 | 2026-04-23 | English | |
| Regulatory Filings 2026 | 2026-04-21 | English | |
| S-8 | 2026-04-20 | English |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46725313 | 10-Q | 2026-05-08 | English | ||
| 46725306 | 8-K | 2026-05-08 | English | ||
| 46725314 | Major Shareholding Notification 2026 | 2026-04-23 | English | ||
| 46725315 | Major Shareholding Notification 2026 | 2026-04-23 | English | ||
| 46725316 | Regulatory Filings 2026 | 2026-04-21 | English | ||
| 46725319 | S-8 | 2026-04-20 | English | ||
| 46725321 | 8-K | 2026-04-20 | English | ||
| 46725323 | POS AM | 2026-04-20 | English | ||
| 46725325 | 424B4 | 2026-04-17 | English | ||
| 46725326 | Regulatory Filings 2026 | 2026-04-17 | English | ||
| 46725329 | S-1MEF | 2026-04-17 | English | ||
| 46725328 | Regulatory Filings 2026 | 2026-04-16 | English | ||
| 46725327 | S-1/A | 2026-04-16 | English | ||
| 46725330 | 8-A12B | 2026-04-15 | English | ||
| 46725336 | S-1/A | 2026-04-13 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cabaletta Bio, Inc.
Develops engineered T cell therapies for B cell-mediated au…
|
CABA | US | Professional, scientific and te… |
|
Caliway
Develops small-molecule therapeutics for medical aesthetics…
|
6919 | TW | Professional, scientific and te… |
|
CALIX LIMITED
Develops industrial carbon capture and sustainable mineral …
|
CXL | AU | Professional, scientific and te… |
|
CAMBIUM BIO LIMITED
Clinical-stage developer of cellular therapies for ophthalm…
|
CMB | AU | Professional, scientific and te… |
|
CAMBRIDGE COGNITION HOLDINGS PLC
Develops digital solutions and a platform for CNS clinical …
|
COG | GB | Professional, scientific and te… |
|
CanBas Co.,Ltd.
A clinical-stage biopharmaceutical company developing novel…
|
4575 | JP | Professional, scientific and te… |
|
Captor Therapeutics S.A.
Develops Targeted Protein Degradation therapies for cancer …
|
CTX | PL | Professional, scientific and te… |
|
Cardiff Oncology, Inc.
A clinical-stage biotech developing cancer therapies that i…
|
CRDF | US | Professional, scientific and te… |
|
Cardio Diagnostics Holdings, Inc.
Develops AI-powered epigenetic and genetic tests for early …
|
CDIO | US | Professional, scientific and te… |
|
Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory therapi…
|
CRDL | CA | Professional, scientific and te… |
Alamar Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72612/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72612 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72612 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72612 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72612}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alamar Biosciences, Inc. (id: 72612)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.